Form 4: Labcorp Executive Brian J. Caveney Reports Stock Transactions

Sentiment:

SEC Form 4


Brian J. Caveney, EVP, President of ED, CMO & CSO at Laboratory Corporation of America Holdings (Labcorp), reports the vesting of restricted stock units and subsequent tax withholding.

Summary

  • On March 27, 2024, Brian J. Caveney vested 11,556 restricted stock units (RSUs) of Laboratory Corporation of America Holdings (Labcorp) Common Stock.
  • Simultaneously, 5,061 shares were withheld to cover tax obligations at a price of $216.57 per share.
  • Following these transactions, Caveney directly owns 27,881.0428 shares of Labcorp Common Stock and 3,740 RSUs.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions, with no inherent positive or negative implications for the company's performance or outlook.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is standard practice for executives to receive and vest stock-based compensation, and for a portion of shares to be withheld to cover tax obligations.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation adjustments.

Key Dates

DateDescription
03/27/2024Vesting of 11,556 Restricted Stock Units and stock withholding for tax obligations.
03/29/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.